Search

Search Constraints

You searched for: Author/Creator Abicht, Jan-Michael

Search Results

1. 40 Days Survival after Orthotopic Cardiac Xenotransplantation of Multi-Transgenic Pig Hearts in a Pig-to-Baboon Model with CD40mAb or CD40L Costimulation Blockade and Xenograft Preservation using "Steens" Cold Blood Cardioplegia Perfusion. (May 2017)

2. 414.7: The Perioperative Cardiac Xenograft Dysfunction (PCXD) Has A Major Impact in (Life-Supporting) Orthotopic (oXTx) Cardiac Xenotransplantation, but Not in the Heterotopic Thoracic (htXTx) Xenotransplantation. (13th September 2022)

3. 414.7: The Perioperative Cardiac Xenograft Dysfunction (PCXD) Has A Major Impact in (Life-Supporting) Orthotopic (oXTx) Cardiac Xenotransplantation, but Not in the Heterotopic Thoracic (htXTx) Xenotransplantation. (13th September 2022)

5. First Experience with the Munich Valsalva Implantation Technique (MuVIT) for Cardiac Output Reduction During Standard and Complex Thoracic Endovascular Aortic Repair. (June 2022)

6. Study for Comparison of CD40-mAb and CD40L-Ab Costimulation Blockade after Life-Supporting Orthotopic Cardiac Xenotransplantation of Multi-Transgenic Pig Hearts into Baboons with a Worldwide First Successful Long-Term Survival. (July 2018)

7. WORLDWIDE FIRST FINALIZED STUDY OF PRECLINICAL LIFE-SUPPORTING ORTHOTOPIC PIG-TO-BABOON CARDIAC XENOTRANSPLANTATION (XT): CONSTANT REPRODUCIBLE 3-MONTHS-SURVIVAL UP TO HALF A YEAR MEETS THE ISHLT GUIDELINES FOR FIRST CLINICAL TRIALS. Issue 3 (September 2020)